Search
for
Sort by
Research 571–600 of 1000+
- Clinical evaluation and treatment response in Patients with non-scarring alopecia: A Prospective Study of 200 Cases
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Psychometric validation of the Spanish alopecia areata–life impact questionnaire
- Role of microneedling in treatment of alopecia areata
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Interest of a vitamin and mineral supplement in the management of telogen effluvium: Clinical study on Brazilian women
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Tofacitinib therapy for children with severe alopecia areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Association of vitamin D level with alopecia areata
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Comparative Efficacy of Topical Tacrolimus 0.1% and Clobetasol Propionate 0.05% in the Treatment of Alopecia Areata (AA)
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- EFFICACY OF PLATELET RICH PLASMA AS MONOTHERAPY IN TREATMENT OF ALOPECIA AREATA.
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Alopecia areata - risk factors, prevention possibilites and therapeutical options
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata